Paksoy provides advice across a broad spectrum of areas including pharmaceuticals, biotechnology, medical devices, nutritional supplements, clinical research and private hospitals.
We assist our clients on a wide range of issues concerning the healthcare and life sciences sector. We provide guidance from product inception to final marketing and commercialisation of products in Turkey.
We also support our clients in drafting contracts regarding manufacturing and distribution of medical devices and medicinal products, devising and implementing compliance programs, in particular with regard to the promotion, transparency rules and public procurement legislation.
We also have substantial experience of the issues affecting healthcare and life sciences companies in the context of M&A transactions.
“ Paksoy is one of the few Turkish firms to gain recognition in this specialist area. ”
PLC Which Lawyer
Featured publications
2 November 2023
Recent developments in Healthcare Legislation – 2023 Summer/Fall Issue
We would like to share with you our information note where we have summarised the latest developments in the healthcare legislation…
3 January 2022
New Regulation on the Licensing of Medicinal Products for Human Use
We have published a new Paksoy briefing: "New Regulation on the Licensing of Medicinal Products for Human Use"
Related contents
21 November 2025
Recent Developments in Healthcare Legislation
New Guideline on the Applications for GMP Inspections of Foreign Manufacturing Facilities. The Guideline on the Applications for GMP…
13 November 2025
Recent Developments in Healthcare Services
Legislative work in the field of healthcare services has gained momentum in the past few days. In this context, the Regulation on Licensing…
21 October 2025
Promotion of Medicinal Products for Human Use
Promotional activities for medicinal products for human use in Turkey are primarily governed by the Law on Pharmaceutical and Medical…
4 September 2025
Paksoy advises Solventum on sale of purification and filtration business to Thermo Fisher
Solventum, an American healthcare company spun off from 3M in 2024, has completed the sale of its purification and filtration business to…
21 July 2025
Recent Developments in Healthcare Legislation – Q2 2025
Amendment to the Regulation on the Clinical Trials of Medicinal Products for Human Use. On 5 June 2025, the Regulation on Clinical Trials…
2 June 2025
Pricing of Medicinal Products for Human Use in Türkiye
Pricing of medicinal products in Türkiye is governed by a comprehensive regulatory framework that imposes specific obligations on…